ebselen and imatinib mesylate

ebselen has been researched along with imatinib mesylate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, LT; Chen, TJ; Chen, YY; Chou, FF; Fang, FM; Huang, HY; Lan, J; Li, CF; Li, SH; Lin, CY; Tai, HC; Yu, SC1

Other Studies

1 other study(ies) available for ebselen and imatinib mesylate

ArticleYear
AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.
    Oncotarget, 2014, Nov-30, Volume: 5, Issue:22

    Topics: Azoles; Benzamides; Cell Line, Tumor; Cell Proliferation; Comparative Genomic Hybridization; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 4; Disease-Free Survival; DNA Mutational Analysis; Flow Cytometry; G1 Phase; Gastrointestinal Stromal Tumors; Gene Dosage; Genotype; Humans; Imatinib Mesylate; Immunohistochemistry; In Situ Hybridization, Fluorescence; Isoindoles; Multivariate Analysis; Oncogene Proteins; Organoselenium Compounds; Piperazines; Predictive Value of Tests; Prognosis; Pyrimidines; Racemases and Epimerases; RNA Interference; Treatment Outcome; Up-Regulation

2014